NICKEL ALLERGIC CONTACT DERMATITIS
|
|
|
- Lynette Rose
- 9 years ago
- Views:
Transcription
1 1 June 2013 Fact Sheet Nickel and Human Health NICKEL ALLERGIC CONTACT DERMATITIS Nickel is one of the most common anthropogenic causes of allergic contact dermatitis (ACD). The reason for the relatively high prevalence of nickel ACD is due to the use of nickel in consumer items that come in direct and prolonged contact with the skin. Although exposure may occur through some occupational settings generally associated with soluble nickel salts, the high prevalence of nickel ACD in the general population is primarily due to consumer dermal exposure to nickel metal in plated articles or some alloys (e.g., jewelry, watches, eyeglasses). Nickel ACD requires prolonged and repeated exposure of the immune system for an individual to become nickelsensitized. Once sensitized, exposure to a sufficient amount of nickel causes ACD reactions by the immune system, called elicitation. The release of nickel ions is responsible for causing nickel ACD, which is a threshold effect. Alloys such as many stainless steels contain nickel but do not release a sufficient amount of nickel-ions to cause an individual to become nickel sensitized or have a nickel ACD reaction if they are already nickelsensitized. Exposure to nickel ions through inhalation and oral exposure has not been shown to induce nickel-sensitization in non-nickel-sensitized individuals. Rather, oral exposure in some cases has been demonstrated to reduce susceptibility or even result in immunotolerance to dermal nickel sensitization. Legislation in the European Union has been put in place to decrease the consumer dermal exposure to nickelreleasing articles so as to reduce the prevalence of nickel-sensitized individuals and the number of nickel ACD reactions in already nickel-sensitized individuals. Occupational exposure is being reduced through risk management measures within the workplaces. The nickel industry supports and encourages these practices to reduce and minimize nickel allergic contact dermatitis. Nickel releasing jewelry is a common cause of nickel allergic contact dermatitis. 1 INTRODUCTION Many chemical agents, including nickel, can cause allergic contact dermatitis (ACD) which results in inflammation of areas of the skin in sensitized individuals. Elemental nickel and sweat-soluble nickel salts both cause ACD by sweat solubilization (corrosion) of nickel and the formation of nickel ions, during intimate and prolonged contact with the skin and sweat. The rate of nickel ion release to the skin is dependent primarily on the specific substance having contact with the skin. Non-occupational exposure to nickel in Europe, primarily through jewelry in piercings (e.g., earrings) and direct and prolonged skin contact with nickel-containing jewelry, clothing fasteners, etc., has reportedly sensitized from 5-17% of females and from 0.5-3% of males. The nickel industry supports the intent of legislation such as the European Union's Nickel Directive (94/27/EC as amended), now subsumed into the REACH Regulation Annex XVII. This prohibits the use of nickel in products intended for direct and prolonged skin contact if this will result in solubilization of nickel at a rate exceeding 0.5 micrograms per square centimeter per week or in the case of body piercing, a lower rate of 0.2 micrograms per square centimeter per week. Furthermore, the nickel industry accepts the expert opinion of dermatologists who state that such a prohibition will by itself reduce the incidence of nickel ACD in the general population to very low levels. There is no justification for banning nickel from uses in general consumer products unless there is clear evidence, resulting from a detailed risk assessment, that such a use poses a significant health risk. The Danish EPA (Environmental Protection Agency) conducted a target risk assessment on nickel as used in euro coins. (1) The conclusion of this report for consumers was: There is at present no need for further information or testing or risk reduction measures beyond those which are being applied already. The use of nickel in coinage does not pose a health risk for the general population because this application does not involve direct and prolonged contact with the skin under normal handling and use. Many populations, including North Americans, that have used nickel in coinage for many decades, show few cases of nickel ACD associated with coins. The use of most stainless steel alloys in consumer products does not constitute a health risk from nickel ACD both because most stainless steels have not demonstrated nickel ACD in nickelsensitized individuals, nor do they release sufficient amount of nickel ions, and/or because such items would not come into contact with the skin at the required intimacy or for the required time to cause nickel sensitization reactions. The nickel industry will continue to be supportive of scientific research on the mechanism of nickel ACD, in improving tests for nickel sensitivity, and in conducting studies to ensure that specific uses of nickel do not pose health risks for the general population. While technical in nature, this is not a peer-reviewed science paper. It is intended to be an overview of a topic that has generated very extensive and well-reported literature over a long time period. 1
2 2 WHAT IS ALLERGIC CONTACT DERMATITIS? Many chemical agents such as poison ivy, rubber accelerators, epoxy resins, certain solvents, certain perfumes, and some metals and soluble salts of metals (e.g., nickel, chromium, cobalt, gold, mercury) are able to cause ACD. This condition is characterized by a broad range of skin symptoms ranging from dryness, chapping, and inflammation to eczema and blisters. Discomfort is caused by skin inflammation and itching. There are usually social stigmas present due to the discolorations and eruptions of local areas of the skin that are visible to others. Nickel ACD from nickel releasing necklace clasp. Nickel ACD is not an inherited condition. It is related to intimate and prolonged skin contact (i.e., exposure) by nickel-containing materials, nickel metal, or nickel soluble salts. Nickel ACD was first noticed in occupational settings where soluble forms of nickel came into contact with worker s skin. Individuals working in electroplating shops, in battery manufacturing, and with nickel catalysts were the most susceptible to exposure. Work related nickel dermatitis is now relatively rare due to preventative occupational hygiene measures. Non-occupational nickel dermal sensitization is well known. It was first observed in individuals who had skin contact with clothing items having nickel-coated buckles, zippers, and clasps. The incidence increased with the increasing use of nickel plated jewelry. A common cause of nickel dermatitis is now body piercing, which may involve inserting nickel-releasing studs into the wound to prevent closure during healing. Once healed, with the stud removed, additional contact with nickel in the pierced area may occur by wearing jewelry or posts in piercings that release a significant amount of nickel ions. 3 WHAT ARE THE CONDITIONS NECESSARY FOR INDUCING NICKEL ACD? The development of nickel ACD requires that an individual become immunologically sensitized to nickel. This is termed the induction phase or sensitization phase and the length of this phase varies greatly between individuals. It can range from 1-3 weeks to develop, following hours to weeks of intimate contact in a piercing or on the skin with a form of nickel that can release a sufficient amount of solubilized nickel ions onto the skin. The quantity of nickel ions that is sufficient to induce sensitivity varies with the individual. If the skin is already damaged, sensitization may be induced more quickly and by lower amounts of the solubilized nickel. Temperature, the presence of other allergic conditions, gender, and age may also be determining factors for susceptibility, the amount of nickel ions required for a reaction, and the time to develop sensitization to nickel. Induction of ACD most commonly originates from body piercing but is also more likely if skin exposure is combined with irritants and/or moist skin. A nickel sensitized individual, when re-exposed to nickel ions on the skin in sufficient amounts, may have an allergic response within a matter of hours. This is termed the elicitation phase, which often occurs at a lower concentration of nickel ions than required for inducing sensitization in the first place. The elicitation of nickel ACD usually occurs at the site of exposure but can occur in skin remote from the site of contact with nickel where previous nickel sensitization reactions have occurred. (2) Whilst systemic elicitation of ACD in individuals sensitized by direct skin contact is well documented for a small proportion of nickel-sensitized individuals, there exists some controversy (3) about the ability to sensitize individuals when taken orally, intravenously, or inhaled. Only about 1-10% of dietary nickel is absorbed by the body. Average daily ingested intake of nickel is about 200 micrograms. A few studies have shown that nickelsensitive individuals orally given >5,000 micrograms nickel (as NiSO 4 ) as a single dose had a dermal allergic response. While such exposures are far in excess of those encountered in normal diets, some researchers suggest that dietary control of nickel intake may help in the ongoing treatment of nickel ACD caused by other sources. These researchers have correctly identified foods high in nickel content (e.g., nuts, chocolate, beans), but they have sometimes incorrectly advocated the avoidance of cutlery, bowls, etc. made from stainless steel, which do not release significant amounts of nickel. A correlation between nickel ACD and asthma due to respiratory exposure to soluble nickel has not been demonstrated. This lack of association is likely the result of different immunological mechanisms of the two types of allergy. Respiratory sensitization is known to be a type 1 mediated immunological reaction, whereas skin sensitization involves a type 4 reaction. 4 WHAT PORTION OF THE POPULATION MAY BE AT RISK? Studies of the prevalence of nickel sensitivity generally show that in the general population up to 17% of women and 3% of men are nickel sensitive. (4) Public health advocates are using these figures to project that over 10% of the world's population that is, hundreds of millions of people, are at risk of being sensitized to nickel. This projection, however, fails to take into account the method of exposure that has likely caused the current prevalence. It is generally agreed among dermatologists that "the principal way in which sensitization can be induced in susceptible individuals appears to be by contact with a high concentration of sweat-soluble nickel from a localized area." (5) Nickel-releasing ear-piercing studs, nickel-plated jewelry, and nickel-plated clothing clasps are viewed as the items primarily responsible for the current prevalence of nickel sensitivity. Bodypiercing practices are increasing in North America and Europe. The significant differences in prevalence between females and males is sometimes correlated with the much higher prevalence of ear-piercing among women, particularly in European cultures, but other factors such as hormone differences and the tendency for 2
3 females to wear more and/or cheaper jewelry than males may also play a role. (6) An important question is: If the use of nickel-releasing materials in jewelry and ear-piercing studs were reduced, what would be the resulting long-term risk of nickel ACD among the population? Regulatory controls (similar to the Nickel Directive and REACH) were imposed in certain Scandinavian countries towards the end of the last century and many reports have now demonstrated a significant reduction in the prevalence of individuals testing positive for nickel sensitization. (7-14) The Nickel Directive has now been in place in Europe as a regulatory control since 1998 and more widespread support of the earlier Scandinavian studies of decreased sensitization to nickel in European countries has developed. 5 WHAT REGULATORY CONTROLS ARE CURRENTLY IN PLACE? In 1991, Denmark banned the sale of nickel-releasing objects that contact the skin for prolonged times and which release approximately >0.5 micrograms/cm 2 /week as measured by a dimethylglyoxime (DMG) test. (15) not experience ACD at this level of nickel release and most, if not all, of individuals not previously sensitized require substantially higher concentrations than 0.5 micrograms nickel/cm2/week to be released to the skin for nickel sensitization to occur. (17) EN 1811:1998 (18) (Reference Test Method for Release of Nickel from Products Intended to Come into Direct and Prolonged Contact with the Skin) originally came into force in 1998 and its use to test articles for nickel release was successful in removing from the market many unsuitable articles that could have caused nickel dermatitis. However, the test was not sufficiently reliable and reproducible. With CEN (Comité Européen de Normalisation, European Committee for Standardization) Mandate M414 an EU working party (CEN TC 347 WG 1) was set up in 2007 with the objective of improving the test procedure. A modified procedure incorporating a corrigendum in May 2012 (EN 1811:2011) (19) has now been approved and is coming into force. It supersedes EN 1811:1998+A1:2008 which was withdrawn on March 31, The amended Nickel Directive has now been subsumed into the REACH regulation (EC) Annex XVII. (16) This says that nickel: 1. Shall not be used: a. in all post assemblies which are inserted into pierced ears and other pierced parts of the human body unless the rate of nickel release from such post assemblies is less than 0.2 μg/cm 2 /week (migration limit); b. in articles intended to come into direct and prolonged contact with the skin such as: earrings, necklaces, bracelets and chains, anklets, finger rings, wrist-watch cases, watch straps and tighteners, rivet buttons, tighteners, rivets, zippers and metal marks, when these are used in garments, if the rate of nickel release from the parts of these articles coming into direct and prolonged contact with the skin is greater than 0.5 μg/cm 2 /week; and c. in articles such as those listed in point (b) where these have a non-nickel coating unless such coating is sufficient to ensure that the rate of nickel release from those parts of such articles coming into direct and prolonged contact with the skin will not exceed 0.5 μg/cm 2 /week for a period of at least two years of normal use of the article. 2. Articles which are the subject of paragraph 1, shall not be placed on the market unless they conform to the requirements set out in those points. It should be noted that the 0.5 micrograms nickel/cm 2 /week is as determined in the nickel release standard EN 1811 and it is understood that the release rates would not protect 100% of sensitized people from elicitation of ACD. However, clinical data indicates that the vast majority of sensitized individuals would Pink positive DMG test for nickel release from jeans button. However, some groups (including the United Kingdom and the spectacle manufacturing industry) do not believe that the modified EN 1811 meets the requirements of the market and the EU issued a new mandate (M448) to the spectacle industry to produce an entirely new test procedure that will reliably and reproducibly identify articles that can be safely used without the risk of inducing nickel sensitization. This is being carried out by CEN TC 170 WG 8 and whilst this work is in progress the spectacle industry will continue to use the old EN 1811:1998 in a renumbered standard, EN 16128:2011. Also in use is a standard to test articles qualitatively for nickel release (a relatively easy, quick, and cheap process compared with EN 1811). This is EN 12471:1998, (Screening Tests for Nickel Release from Alloys and Coatings in Items that Come into Direct and Prolonged Contact with the Skin), which was reviewed and revised before being re-issued as EN 12471:2002. For coated products there is a requirement that the article should not release nickel above the specified limits after two years of normal use and this was covered by EN 12472:1998 (Method for the Simulation of Wear and Corrosion for the Detection of Nickel Release from Coated Item). This period of use was simulated by tumbling the articles in a mixture of abrasive paste and ceramic particles. However, this was judged to be too aggressive and, therefore, after considerable investigation, the ceramic particles were replaced by wood and nutshells and the method of tumbling was specified in more detail. This resulted in the re-issue of the standard as EN 3
4 12472:2005 and, after a corrigendum in 2009, as EN 12472:2005+A1:2009. A very small part of the population is hypersensitive to nickel. These individuals react to lower concentrations of nickel on the skin and potentially by oral exposure than most nickel-sensitive individuals. Prevention of elicitation in these individuals is important and is done on a case-by-case basis. Regulation and prevention of dermal nickel sensitization of the general population is not intended to protect hypersensitive individuals. 6 WHAT IS THE NICKEL INDUSTRY'S POSITION CONCERNING NICKEL ACD? The nickel industry: Recognizes that nickel ACD can be a significant health and social problem for individuals who have become sensitized. Accepts the opinion of experts in dermatology that induction of nickel dermal sensitivity is caused principally by body piercing or prolonged and intimate contact by the skin with a sweat-soluble form of nickel. Accepts the opinion of experts that the use of nickel in earpiercing studs, jewelry and clothing clasps, and zippers is the prevailing method of inducing nickel ACD. The nickel industry supports regulations such as the EU Directive (now REACH) to restrict the release of nickel from articles used in direct and prolonged contact with the skin and piercing studs. Supports the use of protective equipment and training for workers routinely handling nickel substances in industrial environments. Concurs with the Consensus Document from the 1997 Nickel Dermatitis Workshop that transient, short-term contact with nickel-containing articles such as coinage, keys, handles, tools, and other equipment does not appear to be a factor in the induction of an allergic contact dermatitis within the general population. If the contact is of short duration and infrequent, the risk of sensitization is negligible, and the risk of the elicitation of dermatitis is limited. (4) Believes that adoption of regulations such as the Nickel Directive in the EU will result in a reduction in the prevalence of nickel ACD to an acceptable level in other places in the world also. Photo by uhuru1701 Nickel is used in many coins around the world.* Is not aware of large numbers of cases of nickel ACD having been associated with nickel in coinage despite more than a century of use in billions of coins handled by billions of people. In particular, there is no epidemiological report of adverse effects in the Canadian population from having pure nickel 5, 10, and 25 cent coins in circulation for decades. Also, there is no evidence of significant adverse dermatological effects in the United States population from having a 25% nickel-copper clad 25 cent coin. Believes that provocation studies where coins or tools are kept in intensive and prolonged contact with the skin of sensitized individuals and which elicit an allergic response, are not relevant to coinage or tool use by the general population. Conducted a key study that demonstrated that continuous handling of nickel-containing coins for 8 hours/day for multiple consecutive days did not elicit a nickel ACD reaction in any of the nickel-sensitized or non-nickel-sensitized individuals tested. (20) Notes that transient skin contact with nickel-containing coins by the general population has not been shown to induce ACD or cause reactions in nickel-sensitized individuals. States that if for the great majority of the general population, tools are unlikely to result in a dose sufficient to cause ACD or induce nickel sensitization. 7 PRESENT STATE OF SCIENTIFIC KNOWLEDGE Nickel ACD is not a new concern and has been studied by many groups. While there are still many questions on this issue to be answered, below is a summary of the current information. It is difficult to use animals to study nickel ACD because animals display different immune responses than do humans. For ethical reasons, it is difficult to expose human subjects to a substance that may compromise their health. Scientists therefore have a dilemma. They would like to understand the mechanisms involved in human nickel ACD, but they are not confident that the animals available for experimentation are good surrogates. The current thinking is that nickel by itself is not antigenic, but rather that nickel complexes involving histidines or proteins are bound to Langerhans' cells. These cells, located in the basal layer of the epidermis, actively participate in cutaneous immune regulation and surveillance and are responsible for antigen processing and presenting the antigen to T- lymphocyte cells. The bound Langerhans' cells migrate to regional lymph nodes where further processing of the antigen occurs and ultimately a population of altered nickelspecific T-lymphocytes are created and recirculated where they may enter peripheral tissue (including the skin). At this point the individual is sensitized. In the sensitized individual, when antigen-specific T- lymphocytes encounter the antigen (i.e., nickel ions), they release lymphokines, which are proteins that cause a wide variety of actions on other cells including stimulation of macrophages and natural killer cells and other responses. With a sufficient amounts of stimulation, tissue inflammation and other allergic responses occur in an attempt to rid the body of the foreign entity. This integrated response is what causes the allergic contact dermatitis. The condition of the skin is very important in nickel ACD response. Intact skin with normal barriers is less susceptible (i.e., less permeable to nickel ions) to developing an ACD than skin that is broken or otherwise abnormal regarding permeability of the skin. Heat, humidity, and increased 4
5 sweat promote the likelihood and speed with which nickel ions are presented to the skin. (21) There is no known means of reversing immuno-activation (the sensitized condition). However, because the precise mechanism by which nickel ions and Langerhans' cells and T-lymphocytes interact is not understood, dermatologists are reluctant to conclude that such a reversal is biologically impossible. The feeling is that knowledge about the mechanism will result in awareness of how to "turn off" the immune system to nickel. There is evidence that immunotolerance is possible. First, it is noteworthy that the nickel-producing and nickel-using industries very rarely have workers presenting symptoms of nickel ACD. It would be expected that a group of workers routinely coming into direct skin contact with various forms of nickel metal and salts would display ACD. The fact that it is not seen may be due to a tolerance that the workers acquire over time via an alternate route of exposure (inhalation or ingestion) that causes no allergic reaction by the immune system, even when higher nickel exposures are received later. Second, literature (22) indicates that dental braces made from high-nickel alloys (e.g., nickel-chromium with 60-80% nickel) resulted in nickel-tolerance in girls subsequently having their ears pierced compared to a higher nickel sensitivity in girls who had their ears pierced, but did not wear such dental braces prior to ear-piercing. This tolerance may be caused by a mechanism involving low nickel exposure orally over time. Third, immunotolerance in animals (mice) has been shown by nickel exposure either intravenously or orally, with T-lymphocytes in nickel-tolerant mice being transferable to other mice to make them nickel-tolerant. Photo by Hot Grill Orthodontic braces may result in immunotolerance to nickel ACD. Diagnosis of nickel-sensitivity is done via the patch test, which establishes contact of soluble nickel against a small portion of occluded skin. This is done under a specified procedure (23) to limit misinterpretation due to irritation rather than allergic response. An appropriate concentration of a solution of nickel sulfate is placed on a metallic or filter paper disc backed by aluminum foil (impermeable to water) and attached to the subject's upper back or upper arms by adhesive tape so that the skin area under test is completely covered. The patch is left in place for two days and then removed; the skin is evaluated for the severity of inflammation. There is some concern that unsensitized people can become sensitized by using this test. It is also capable of giving both false negative and false positive results. Nevertheless, it is by far the most routine diagnostic test for determining whether a person is nickel-sensitive along with history of reaction to nickel-containing materials. In the 1960s another test, called the lymphocyte proliferation test (LPT), or the lymphocyte transformation test (LTT), was developed. Its advantage is that it uses a blood sample from a suspected nickel-sensitized individual and is performed in vitro, thus avoiding the risk of having nickel in contact with the skin. The LPT (or LTT) is based on the fact that nickelsensitized individuals have T-lymphocytes primed and ready for the nickel antigen being presented. The test pretreats the blood sample so as to concentrate the T-lymphocytes and then incubates them with a concentration of Ni. In the nickel-sensitive person, the presence of nickel will cause the primed T-lymphocytes to "turn-on" and elicit an immune response. They "turn-on" by doing several things, one of which is to divide rapidly (proliferate). If a radioactively labeled DNA precursor iododeoxyuridine is also present in the culture, the new T-lymphocytes will use this to synthesize new DNA for their daughter cells. Following separation of the T-lymphocytes, an increase in radioactivity above a measured control (to account for normal cell division) is indicative of high cell proliferation, which means the original T-lymphocytes reacted to the nickel present. This test is only now becoming a clinical tool and more work is required to correlate it with patch test results and to make it reliable. 8 CONCLUSIONS Nickel ACD is a significant human health concern due to the relatively high prevalence in the general population. However, the risk of becoming nickel sensitized or having a nickel ACD reaction (if already nickel-sensitized) can be minimized through reduced exposure. In the workplace, exposure reduction includes personal protective equipment and other risk management measures. For consumers, exposure can be reduced through restriction of direct and prolonged exposure to items releasing nickel in amounts greater than the threshold for nickel ACD. 9 REFERENCES 1. Danish EPA (Environmental Protection Agency) Risk Assessment Targeted Report: Nickel as Used in Euro Coins. Draft of 2, June. CAS No , EINECS No Occupational Medicine rd Edition, ed. by Zenz, C.; Dickerson, O.B.; Horvath, E.P. (Eds). St. Louis: Mosby. 3. Menné, T.; Veien, N.; Sjolin, K-E.; Maibach, H.I Systemic contact dermatitis. Amer. J. of Contact Dermatitis 5(1): Thyssen, J.P., Menné, T Metal allergy a review on exposures, penetration, genetics, prevalence, and clinical implications. Chem. Res. Toxicol. 23(2): Consensus Document from the NiPERA-Sponsored Nickel Dermatitis Workshop, March 17-18, 1997, Brussels, Belgium. NiPERA, Durham, NC, USA. 6. Kwangsukstith, C.; Maibach, H.I Effect of age and sex on the induction and elicitation of allergic contact dermatitis. Contact Dermatitis 33: Johansen, J.D.; Menné, T.; Christophersen, J.; Kaaber, K.; Veien, N Changes in the pattern of sensitization to common contact allergens in Denmark between and , with a special view to the effect of preventive strategies. Br. J. Dermatol. 142:
6 8. Mattila, L.; Kilpeläinen, M.; Terho, E.O.; Koskenvuo, M.; Helenius, H.; Kalimo, K Prevalence of nickel allergy among Finnish university students in Contact Dermatitis 44: Ehrlich, A.; Kucenic, M.; Belsito, D.V Role of body piercing in the induction of metal allergies. Contact Dermatitis 12: Lu, L.K.; Warshaw, E.M.; Dunnick, C.A Prevention of nickel allergy: the case for regulation? Dermatol Clin. 27(2): Thyssen, J.P.; Linneberg, A.; Menné, T.; Nielsen, N.H.; Johansen, J.D Contact allergy to allergens of the TRUE-test (panels 1 and 2) has decreased modestly in the general population. Br. J. Dermatol. 161(5): Thyssen, J.P.; Johansen, J.D.; Menné, T.; Nielsen, N.H.; Linneberg, A Nickel allergy in Danish women before and after nickel regulation. N. Engl. J. Med. 360: Carøe, C.; Andersen, K.E.; Mortz, C.G Fluctuations in the prevalence of nickel and cobalt allergy in eczema patients patch tested after implementation of the nickel regulation in Denmark. Contact Dermatitis 64(3): Thyssen, J.P.; Hald, M.; Avnstorp, C.; Veien, N.K.; Lauerberg, G.; Nielsen, N.H.; Kaaber, K.; Kristensen, B.; Kristensen, O.; Thormann, J.; Vissing, S.; Menné, T.; Johansen, J.D Characteristics of nickel-allergic dermatitis patients seen in private dermatology clinics in Denmark: A Questionnaire Study. Acta Derm. Venereol. 89: Kanerva, L.; Sipiläinen-Malm, T.; Estlander, T.; Zitting, A.; Jolanki, R.; Tarvainen, K Contact Dermatitis 31(5): European Commission REACH Annex xvii Restrictions on the manufacture, placing on the market and use of certain dangerous substances, preparations and articles. Official Journal of the European Union L 396/ str/annex_xvii_301206_en.pdf (last accessed June 2013) 17. Gawkrodger, D.J Nickel dermatitis: how much nickel is safe? Contact Dermatitis 35: European Committee for Standardization (CEN) EN Reference Test Method for Release of Nickel from Products Intended to Come into Direct and Prolonged Contact with the Skin. Brussels, CEN. 19. European Committee for Standardization (CEN) EN 1811:2011. Reference test method for release of nickel from all post assemblies which are inserted into pierced parts of the human body and articles intended to come into direct and prolonged contact with the skin. CEN/TC Methods for analysis of allergens. Brussels, CEN. 20. Zhai, H.; Chew, A.-L.; Bashir, S.J.; Reagan, K.E.; Hostynek, J.J.; Maibach, H.I Provocative use test of Ni coins in Ni sensitized subjects & controls. Br. J. Dermatol. 149: Hemingway, J.D.; Molokhia, M.M The dissolution of metallic nickel in artificial sweat. Contact Dermatitis 16: van Hoogstraten, I.M.W.; Andersen, K.E.; Von Blomberg, B.M.E.; Boden, D.; Bruynzeel, D.P.; Burrows, D.; Camarasa, J.G.; Dooms-Goossens, A.; Kraal, G.; Lahti, A.; Menné, T.; Rycroft, R.J.G.; Shaw, S.; Todd, D.; Vreeburg, K.J.J.; Wilkinson, J.D.; Scheper, R.J Reduced frequency of nickel allergy upon oral nickel contact at an early age. Clin. Exp. Immunol. 85: Cronin, E Contact Dermatitis. Churchill-Livingstone: London. 9.1 ADDITIONAL REFERENCES * Some rights reserved by photographer uhuru o/in/photostream/ (last accessed June 2013) Some right reserved by photographer Hot Grill otostream (last accessed June 2013) 6
7 Fact Sheets on Nickel and Human Health This is the first in a series of fact sheets addressing issues specific to the evaluation of risks to humans associated with nickel-containing substances and materials. The fact sheets are intended to assist the reader in understanding the complex issues and concepts associated with assessment of human health hazards, doseresponse relationships, and exposure by summarizing key technical information and providing guidance for implementation. NiPERA welcomes questions about the concepts and approaches implemented for nickel allergic contact Dermatitis. For inquiries, please contact: NiPERA, Inc Meridian Parkway, Suite 240 Durham, NC 27713, USA Telephone: Katherine E. Heim, Ph.D., DABT [email protected] This fact sheet was prepared by: Peter Cutler, Ph.D. Nickel Institute Brussels, Belgium Tel: [email protected] Katherine Heim, Ph.D., DABT NiPERA 7
The outcome of dimethylglyoxime testing in a sample of cell phones in Denmark
Contact Dermatitis 2008 doi: 10.1111/j.1600-0536.2008.01350.x Copyright # Blackwell Munksgaard 2008 CONTACT DERMATITIS The outcome of dimethylglyoxime testing in a sample of cell phones in Denmark JACOB
European Respiratory Society (ERS), The European Lung White Book Respiratory Health and Disease in Europe, 2013. 3
EFA response to the European Commission public consultation on fragrance allergens in the framework of Regulation (EC) No. 1223/2009 of the European Parliament and of the Council on cosmetic products The
Occupational contact dermatitis
Occupational contact dermatitis sources of exposure and clinical aspects Dr Nadia NIKOLOVA-PAVAGEAU Medical Studies and Assistance Division, INRS Occupational contact dermatitis Occupational skin disease:
European Regulation and Stainless Steel
European Regulation and Stainless Steel Patricia Koundakjian Eurofer, Brussels, Belgium Introduction This paper addresses European health and environmental regulation as it applies to the product, stainless
Dental amalgams & alternative materials
page 1/8 Source document: Tooth filling materials SCENIHR / SCHER (2008) Dental amalgams & alternative materials Summary & Details: GreenFacts Context - Amalgam is a combination of mercury with other metals
OCCUPATIONAL SKIN DISEASES IN NURSES
International Journal of Occupational Medicine and Environmental Health, 2003; 16(3): 241 247 OCCUPATIONAL SKIN DISEASES IN NURSES RUTA TELKSNIENE 1 and VIDMANTAS JANUSKEVICIUS 2 1 Department of Environmental
001637/EU XXV. GP. Eingelangt am 12/11/13 COUNCIL OF THE EUROPEAN UNION. Brussels, 12 November 2013 (OR. en) 16119/13
001637/EU XXV. GP Eingelangt am 12/11/13 COUNCIL OF THE EUROPEAN UNION Brussels, 12 November 2013 (OR. en) 16119/13 MI 1021 CHIMIE 126 ENV 1061 COMPET 819 ENT 310 COVER NOTE From: European Commission date
Module Three. Risk Assessment
Module Three Risk Assessment 136 Module Three Introduction to Risk Assessment Time Allotted: 90 Minutes Objectives: Upon completion of this module, the learner will be able to # Define and understand the
sensitization in a general population Lars Kåre Dotterud
ORIGINAL ARTICLE The Prevalence of allergic contact sensitization in a general population in Tromsø, Norway Lars Kåre Dotterud Department of Dermatology, University Hospital of Northern Norway, Tromsø,
Allergies and Autoimmune Inner Ear Disease
Allergies and Autoimmune Inner Ear Disease Allergy is the term used to describe an over-reaction of the body to a substance that is normally harmless to most people. This substance is called an allergen,
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S1A. Current Step 4 version
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE GUIDELINE ON THE NEED FOR CARCINOGENICITY STUDIES
Allergies: ENT and Allergy Center of Missouri YOUR GUIDE TO TESTING AND TREATMENT. University of Missouri Health Care
Allergies: YOUR GUIDE TO TESTING AND TREATMENT ENT and Allergy Center of Missouri University of Missouri Health Care 812 N. Keene St., Columbia, MO 65201 (573) 817-3000 www.muhealth.org WHAT CAUSES ALLERGIES
MATERIAL SAFETY DATA SHEET
Page 1 of 5 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
Risk assessment and regulation of tattoo inks in the EU
Risk assessment and regulation of tattoo inks in the EU Paul Janssen Current situation: Tattoo application in a regulatory vacuum : Is not a medical treatment Is not a cosmetic treatment No EU-regulation
Report 340301002/2009 J. Ezendam J.D. te Biesebeek S.W.P. Wijnhoven. The presence of fragrance allergens in scented consumer products
Report 340301002/2009 J. Ezendam J.D. te Biesebeek S.W.P. Wijnhoven The presence of fragrance allergens in scented consumer products RIVM letter report 340301002/2009 The presence of fragrance allergens
Staff Skin Care Policy
This is an official Northern Trust policy and should not be edited in any way Staff Skin Care Policy Reference Number: NHSCT/10/350 Target audience: All Trust staff and in particular those involved in
GPS Safety Summary DIPROPYLENE GLYCOL DIACRYLATE
GPS Safety Summary Substance Name: DIPROPYLENE GLYCOL DIACRYLATE 1. General Statement DPGDA is a difunctional acrylate monomer which can be polymerised by free radicals. In particular, DPGDA is designed
2) Macrophages function to engulf and present antigen to other immune cells.
Immunology The immune system has specificity and memory. It specifically recognizes different antigens and has memory for these same antigens the next time they are encountered. The Cellular Components
SAFETY DATA SHEET EVO-STIK GRIPFILL SOLVENT FREE (Irl)
Revision Date December 2014 SAFETY DATA SHEET According to Regulation (EC) No 1907/2006 1 / 6 SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1. Product identifier Product
PERSONAL PROTECTIVE EQUIPMENT POLICY & GUIDANCE
Health and Safety Policy PERSONAL PROTECTIVE EQUIPMENT POLICY & GUIDANCE ROYAL FREE HOSPITAL NHS TRUST & SCHOOL OF MEDICINE CONTENTS 1. SUMMARY OF THE REGULATIONS 2. INTRODUCTION 3. DEFINITION OF PERSONAL
3 Food Standards Agency, London, UK
Chapter six From Hazard to Risk e Assessing the Risk Charlotte Bernhard Madsen 1, Geert Houben 2, Sue Hattersley 3, Rene W.R. Crevel 4, Ben C. Remington 5, Joseph L. Baumert 5 1 DVM Research Leader Division
4. Cryogenic gloves are generally designed to protect the hands from intense cold or heat.
PROTECTIVE GLOVES In many University laboratories, exposure to chemicals, infectious agents, sharp objects, extreme temperatures and other hazards can create a potential for injury to the hand. Wherever
GPS Safety Summary. Substance Name: ETHOXYLATED TRIMETHYLOLPROPANE TRIACRYLATE
GPS Safety Summary Substance Name: ETHOXYLATED TRIMETHYLOLPROPANE TRIACRYLATE 1. General Statement SR 454 is a trifunctional low viscosity acrylate monomer for use in ultra violet and electron beam curing
Material Safety Data Sheet
Material Safety Data Sheet Regulation (EC) No 1907/2006 Version 3.0 Revision Date 01/09/2014 Date 13.03.2015 1. IDENTIFICATION OF THE MIXTURE AND COMPANY IDENTIFICATION 1.1 Product Tags Product Name: MetZyme
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL GUIDELINES ON MEDICAL DEVICES
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single Market : regulatory environment, standardisation and New Approach Pressure equipment, medical devices, metrology MEDDEV. 2.5/9 rev.1 February 2004
Material Safety Data Sheet
Section 1 Identification of the Material and Supplier Product Name TMA 725 Stainless steel mesh Recommended Use Component for TMA Corporation Termimesh System as a physical barrier for termites Company
SAFETY DATA SHEET EVO-STIK PLUMBERS MAIT
Revision Date November 2012 Revision 9 1 / 5 SAFETY DATA SHEET According to Regulation (EC) No 1907/2006 SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1. Product identifier
ICH Topic S 1 A The Need for Carcinogenicity Studies of Pharmaceuticals. Step 5
European Medicines Agency July 1996 CPMP/ICH/140/95 ICH Topic S 1 A The Need for Carcinogenicity Studies of Pharmaceuticals Step 5 NOTE FOR GUIDANCE ON THE NEED FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS
Inorganic mercury/ elemental mercury General information
Inorganic mercury/ elemental mercury General information Key Points Fire Does not easily burn under normal conditions Reacts with nitric acid and hot concentrated sulphuric acid. May react explosively
GPS Safety Summary HEXANE-1,6-DIOL DIACRYLATE
GPS Safety Summary Substance Name: HEXANE-1,6-DIOL DIACRYLATE 1. General Statement HDDA is a difunctional acrylic monomer which can be polymerised by free radicals. In particular, HDDA is designed for
The Body s Defenses CHAPTER 24
CHAPTER 24 The Body s Defenses PowerPoint Lectures for Essential Biology, Third Edition Neil Campbell, Jane Reece, and Eric Simon Essential Biology with Physiology, Second Edition Neil Campbell, Jane Reece,
Tungsten Heavy Alloy. Densimet, Mallory Metal, Densalloy, High Density Tungsten Alloy
Safety Data Sheet SECTION 1: IDENTIFICATION Chemical Name: Synonyms: CAS #: Tungsten Heavy Alloy Densimet, Mallory Metal, Densalloy, High Density Tungsten Alloy 7440-33-7 (Tungsten), 7440-02-0 (Nickel),
LEGAL REVIEW & UPDATE
LEGAL REVIEW & UPDATE There are lots of laws and regulations designed to protect workers, the general public, and the environment. However, not everyone follows the laws. Many people deliberately break
llergy Testing: When to test, when not to and what to do with the results
llergy Testing: When to test, when not to and what to do with the results Kelly Maples, MD, FAAAAI, FACAAI Assistant Professor of Pediatrics and Internal Medicine CHKD/EVMS Sensitization Allergy The results
: Resin Fibre Discs - Aluminum Oxide, Zirconia Alumina
Resin Fibre Discs - Aluminum Oxide, Zirconia Alumina SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name : Resin Fibre Discs - Aluminum
RISKS TO HEALTH FROM CHROMIUM VI IN CEMENT
EUROPEAN COMMISSION DIRECTORATE-GENERAL HEALTH AND CONSUMER PROTECTION Directorate C - Scientific Opinions Unit C2 Management of Scientific Committees; scientific co-operation and networks Scientific Committee
MATERIAL SAFETY DATA SHEET
MATERIAL SAFETY DATA SHEET 1. PRODUCT IDENTIFICATION 1.1 Product Name: Cyanogen Bromide Fibrinogen Fragments 1.2 Product REF: 459 1.3 Configuration: One (1) vial, 5.0 mg, lyophilized 1.4 Use of Product:
SAFETY DATA SHEET BOSTIK AQUAGRIP 536
Revision Date November 2014 1 / 6 SAFETY DATA SHEET BOSTIK AQUAGRIP 536 According to Regulation (EC) No 1907/2006 SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1.
MATERIAL SAFETY DATA SHEET In accordance with CE Regulation n 1907/2006. Annex II.
Ref.: BA/909 ELSACYFRA Page: 1 of 5 RRR1. Identification of preparation and of the company/undertaking 1.1 Product name: ELSACYFRA 1.2 Use With the exception of products specifically labeled for In Vitro
The Science of Chemical Safety Essential Toxicology - 4. Hazard and Risk. John Duffus & Howard Worth. IUPAC Educators Resource Material IUPAC
The Science of Chemical Safety Essential Toxicology - 4 Hazard and Risk John Duffus & Howard Worth IUPAC Educators Resource Material IUPAC Hazard and Risk - 1 Hazard is the potential of a substance to
Teacher s Guide. Chemicals & Human Health Website. Toxicology Activity
Teacher s Guide Chemicals & Human Health Website www.biology.arizona.edu/chh Toxicology Activity 1. Pre-test - Have the students the questions on the worksheet prior to visiting the website. This is just
Allergy Testing Clinical Coverage Policy No: 1N-1 Amended Date: October 1, 2015. Table of Contents
Table of Contents 1.0 Description of the Procedure, Product, or Service... 1 1.1 Definitions... 1 2.0 Eligible Beneficiaries... 2 2.1 Provisions... 2 2.1.1 General... 2 2.1.2 Specific... 2 2.2 Special
Working safely with metalworking fluids
Working safely with metalworking fluids A guide for employees Introduction This leaflet aims to help employees who work with metalworking fluids understand the main risks to their health. It contains general
SAFETY DATA SHEET ELEGANCE R.T.U.
SAFETY DATA SHEET SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name Product number Internal identification A089 EV Janitorial - Washroom
: MR MUSCLE Window & Glass Cleaner
1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING Product information Product identifier : Relevant identified uses of the substance or mixture and uses advised against : Hard Surface
Health and Safety Guidance
Health and Safety Guidance Guidance on the Classification, Labelling and Packaging (CLP) Regulations GUIDANCE/29/CLP/11 This guidance is aimed at those handling hazardous chemicals; from single substances
Statement of the Chief Medical Health Officer
Statement of the Chief Medical Health Officer June, 2011 Health Concerns About Cellular Phone Transmission Antennae and Base Stations In 2005, in response to community concerns and after reviewing the
: Fairy Professional Original Washing Up Liquid 5L
PROFESSIONAL Fairy Professional Original Washing Up Liquid 5L Date of issue: 17/11/2011 Revision date: Version: 1.0 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1.
Work Health and Safety Regulations: Classification and labelling for workplace hazardous chemicals
code* word Class Category Code* Text Unstable explosive H200 Unstable explosive Division 1.1 H201 Explosive; mass explosion hazard Division 1.2 H202 Explosive; severe projection hazard Explosives Division
9130 Kallo (Kieldrecht) Houston, TX 77015-6544 Phone: +32 3 570 28 78 Phone : 281-452-5951 Email : [email protected] Fax : 281-457-1128
Monument Chemical bvba Johann Haltermann Ltd. Haven 1972, Ketenislaan 3 16717 Jacintoport Blvd. 9130 Kallo (Kieldrecht) Houston, TX 77015-6544 Phone: +32 3 570 28 78 Phone : 281-452-5951 Email : [email protected]
How Does a Doctor Test for AIDS?
Edvo-Kit #S-70 How Does a Doctor Test for AIDS? S-70 Experiment Objective: The Human Immunodefi ciency Virus (HIV) is an infectious agent that causes Acquired Immunodefi ciency Syndrome (AIDS) in humans.
Release of melamine and formaldehyde from dishes and kitchen utensils
Release of melamine and formaldehyde from dishes and kitchen utensils BfR Opinion Nr. 012/2011, 09 March 2011 Melamine resins are polymers and consist of the starting substances (monomers) melamine and
*** SAFETY DATA SHEET ***
*** SAFETY DATA SHEET *** 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING PRODUCT NAME ECCOBOND 50126 FC PART A RECOMMENDED USE SUPPLIER Adhesive ICI Belgium nv (Emerson &
Product Code: VLB4236 310ml cartridges. Substance Name EC No. CAS No. % by Wt Hazard Symbols n Butylacetate 123 86 4 10 30 10.
1 Product and company identification Supplier: The Vapormatic Co Ltd PO Box 58, Kestrel Way Sowton Industrial Estate, Exeter, EX2 7NB, England Phone Number: 00 44 (0)1392 435461 Fax Number: 00 44 (0)1392
EUROPEAN STANDARD EN 343:2003 PROTECTION AGAINST RAIN
EUROPEAN STANDARD EN 343:2003 PROTECTION AGAINST RAIN Published by W. L. Gore & Associates Editorial support Petra Jackisch, Zentrum für Sicherheitstechnik, Erkrath, Germany Suitable protection against
Answers to commonly asked questions from patients with metal-on-metal hip replacements / resurfacings. Contents
Answers to commonly asked questions from patients with metal-on-metal hip replacements / resurfacings John Skinner 1 and Alister Hart 2, Consultant Orthopaedic Surgeons and Directors of the London Implant
: Henko all weather comp B
Revision date: 5-03-2014 : Version: 01.11 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Chemical type Trade name : Mixture Product code : 7236
1) Siderophores are bacterial proteins that compete with animal A) Antibodies. B) Red blood cells. C) Transferrin. D) White blood cells. E) Receptors.
Prof. Lester s BIOL 210 Practice Exam 4 (There is no answer key. Please do not email or ask me for answers.) Chapters 15, 16, 17, 19, HIV/AIDS, TB, Quorum Sensing 1) Siderophores are bacterial proteins
1. PRODUCT AND COMPANY IDENTIFICATION
Safety Data Sheet Revision Date: 9/13/2014 SDS #: SDS-10226-01 1. PRODUCT AND COMPANY IDENTIFICATION Product Description: Hazardous Reagent None Product Code 51-17-02 51-17-01 51-17-04 51-17-03 Hazardous
SAFETY DATA SHEET RINSE AID
SAFETY DATA SHEET SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name Product number Internal identification A031 EV Janitorial - Catering
US Safety Data Sheet GEAR OIL SAE 10W/30 GEAR OIL SAE 10W/30
Page of 5 Company BUCHER AG LANGENTHAL, MOTOREX-Schmiertechnik, CH- 49 Langenthal, Switzerland. Commercial product name and supplier Commercial product name / Designation NFPA HMIS H F R - C B.2.3.4.5.6
Safety data sheet. according to 1907/2006/EC, Article 31. 1237800 Revision: 24.08.2012 Printing date: 25.06.2015
Page: 1 / 5 01 Identification of the substance/mixture and of the company/undertaking Product identifier Trade name: Article number: new: 4000821 old: E-3725 CAS Number: 519156-32-2 Relevant identified
PERSONAL PROTECTIVE EQUIPMENT
PERSONAL PROTECTIVE EQUIPMENT Background The Safety, Health and Welfare at Work Act 2005 applies to employers, employees in all employments and to the self employed. The Act contains provisions for improving
Genetic testing. The difference diagnostics can make. The British In Vitro Diagnostics Association
6 Genetic testing The difference diagnostics can make The British In Vitro Diagnostics Association Genetic INTRODUCTION testing The Department of Health published Our Inheritance, Our Future - Realising
Current version : 2.0.1, issued: 29.08.2012 Replaced version: 2.0.0, issued: 07.03.2012 Region: GB
SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1 Product identifier Trade name Easy Glide Gleitmittel 1.2 Relevant identified uses of the substance or mixture and uses
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II and Regulation (EC) No. 1272/2008 (CLP) - Europe. Bona Wood Floor Cleaner
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II and Regulation (EC) No. 1272/2008 (CLP) - Europe 1. SAFETY DATA SHEET IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING
ASTHMA IN INFANTS AND YOUNG CHILDREN
ASTHMA IN INFANTS AND YOUNG CHILDREN What is Asthma? Asthma is a chronic inflammatory disease of the airways. Symptoms of asthma are variable. That means that they can be mild to severe, intermittent to
Hazardous Substances and New Organisms Act 1996
Hazardous Substances and New Organisms Act 1996 Tattoo and Permanent Makeup Substances Group Standard 2011 Pursuant to section 96B of the Hazardous Substances and New Organisms Act 1996 (the Act), the
WHMIS After GHS: Preparing for Change. Canadian Centre for Occupational Health and Safety
WHMIS After GHS: Preparing for Change Canadian Centre for Occupational Health and Safety 1. About this publication WHMIS is changing. The substance of WHMIS (labels, MSDSs, and training) will remain, but
Conjunctivitis - Pink Eye
Conjunctivitis - Pink Eye Introduction Conjunctivitis is often called pink eye. It causes inflammation of the thin, clear lining inside the eyelid and on the white of the eye. The inflammation gives the
HAZARD COMMUNICATION & THE GLOBAL HARMONIZING SYSTEM EMPLOYEE TRAINING
HAZARD COMMUNICATION & THE GLOBAL HARMONIZING SYSTEM EMPLOYEE TRAINING This easy-to-use Leader s Guide is provided to assist in conducting a successful presentation. Featured are: INTRODUCTION: A brief
The Immune System: A Tutorial
The Immune System: A Tutorial Modeling and Simulation of Biological Systems 21-366B Shlomo Ta asan Images taken from http://rex.nci.nih.gov/behindthenews/uis/uisframe.htm http://copewithcytokines.de/ The
Material Safety Data Sheet 1. PRODUCT AND COMPANY INDENTIFICATION
Material Safety Data Sheet 1. PRODUCT AND COMPANY INDENTIFICATION POWDER 365 - RAL COLOURS Revision date: 09/20/2010 Supplier Powder 365 82 Green Acres Circle Lavonia GA 30553 For non-emergency information
Selective IgA deficiency (slgad) [email protected] 0800 987 8986 www.piduk.org
Selective IgA deficiency (slgad) [email protected] 0800 987 8986 www.piduk.org About this booklet This booklet provides information on selective IgA deficiency (sigad). It has been produced by the PID UK
Document issued on: December 2, 2014. The draft of this document was issued on March 11, 2013. Contains Nonbinding Recommendations
Recommendations for Labeling Medical Products to Inform Users that the Product or Product Container is not Made with Natural Rubber Latex Guidance for Industry and Food and Drug Administration Staff Document
The Silicone Breast Implant Controversy
The Silicone Breast Implant Controversy by Susan E. Kolb, M.D., F.A.C.S. There has been a great deal of controversy regarding the safety of silicone breast implants. For the women who have implants, conflicting
Seasonal Allergies. 1995-2012 The Patient Education Institute, Inc. www.x-plain.com im010101 Last reviewed: 05/30/2012 1
Seasonal Allergies Introduction Seasonal allergies are allergies that develop during certain times of the year. Seasonal allergies are usually a response to pollen from trees, grasses, and weeds. Constant
Tuberculosis Exposure Control Plan for Low Risk Dental Offices
Tuberculosis Exposure Control Plan for Low Risk Dental Offices A. BACKGROUND According to the CDC, approximately one-third of the world s population, almost two billion people, are infected with tuberculosis.
Section 4. Toxicology
Section 4 Toxicology Occupational Health Any chemical you use incorrectly can result in over-exposure leading to adverse health effects immediately or in the future. All hazardous materials can be handled
EU ECOLABEL FOR ABSORBENT HYGIENE PRODUCTS
EU ECOLABEL FOR ABSORBENT HYGIENE PRODUCTS BEUC and EEB position on proposal to be voted on 14 th of March 2014 Contact: Blanca Morales [email protected] & [email protected] Ref.: X/2014/014-05/03/2014
Safety Data Sheet. according to Regulation (EU) No. 1907/2006. 1270-53 Sulfuric Acid 1.0 N
Page 1 of 5 1. Identification of the substance/preparation and of the company/undertaking Identification of the substance or preparation Use of the substance/preparation Water analysis Company/undertaking
GPS Safety Summary. Dodecane-12-lactam
GPS Safety Summary Substance Name: Dodecane-12-lactam 1. General Statement Dodecane-12-lactam is used as a monomer in polymerisation or copolymerisation processes resulting in the manufacture of polyamides.
SAFETY DATA SHEET ZANFEL VERSION 1.5.0
SECTION 1: IDENTIFICATION Product Name: Zanfel Synonyms: Zanfel Wash For Poison Ivy, Oak & Sumac (Urushiol), Zanfel Poison Ivy Wash Manufacturer/Supplier: Zanfel Laboratories, Inc. Address: 6901 N. Knoxville
Safety Data Sheet Deodorant Roll-On Aluminium Free. 1. Identification
1. Identification 1.1. Product identifier Product Identity Alternate Names Product Code: 754 1.2. Relevant identified uses of the substance or mixture and uses advised against Intended use Deodorant Application
MATERIAL SAFETY DATA SHEET COPPER ALLOYS 101, 102, 103, 104, 110, 122, 151, XP5
1.0 PRODUCT AND COMPANY IDENTIFICATION Page 1 of 6 PMX Industries, Inc. 5300 Willow Creek Drive SW Cedar Rapids, Iowa 52404-4303 Emergency: 319-368-7700 TELEPHONE: 319-368-7700 FAX: 319-368-7701 PRODUCT
Information leaflet Printing Inks for Food Packaging
Page 1 of 8 Information leaflet Printing Inks for Food Packaging 1. Introduction Food packaging is printed to provide information to the final consumer in accordance with Directive 2000/13/EC relating
Applications of nanotechnology: Cosmetics
Applications of nanotechnology: Cosmetics Course on Health Effects of Engineered Nanomaterials Finnish Institute of Occupational Health, 23 April 2013 Sari Karjomaa Finnish Cosmetic, Toiletry and Detergent
402 Adopted: 24 Feb 1987
OECD GUIDELINE FOR TESTING OF CHEMICALS Adopted: 24 Feb 1987 1. I N T R O D U C T O R Y I N F O R M A T I O N P r e r e q u i s i t e s Solid or liquid test substance Chemical identification of test substance
10. T and B cells are types of a. endocrine cells. c. lymphocytes. b. platelets. d. complement cells.
Virus and Immune System Review Directions: Write your answers on a separate piece of paper. 1. Why does a cut in the skin threaten the body s nonspecific defenses against disease? a. If a cut bleeds, disease-fighting
SAFETY DATA SHEET Deb Protect Plus
Revision Date 15/02/2011 Supersedes date 08/02/2011 SAFETY DATA SHEET SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1. Product identifier Product name Product No.
GHS - GLOBALLY HARMONIZED SYSTEM
GHS - GLOBALLY HARMONIZED SYSTEM of Classification and Labelling of Chemicals GHS is a system proposed by the United Nations (UN) for the harmonised world-wide classification and labelling of chemical
ZOVIRAX Cold Sore Cream
Data Sheet ZOVIRAX Cold Sore Cream Aciclovir 5% w/w Presentation Topical cream Indications ZOVIRAX Cold Sore Cream is indicated for the treatment of Herpes simplex virus infections of the lips and face
SIGMA-ALDRICH. Material Safety Data Sheet Version 4.0 Revision Date 02/27/2010 Print Date 08/25/2011
SIGMAALDRICH sigmaaldrich.com Material Safety Data Sheet Version 4.0 Revision Date 02/27/2010 Print Date 08/25/2011 1. PRODUCT AND COMPANY IDENTIFICATION Product name : Product Number : G7253 Brand : Sigma
